Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
TRILLION ENERGY’S WEST AKCAKOCA WELL ENTERS PRODUCTION (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medexus Pharmaceuticals Inc Ordinary Shares
T.MDP
Alternate Symbol(s):
T.MDP.DB
|
MEDXF
Healthcare
Drug Manufacturers - Major
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American...
commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(8)
•••
GoldenArm1
X
Post by
GoldenArm1
on Feb 28, 2023 4:24pm
Back on and MDP
Any reason why Yahoo is showing the stock was halted on 23rd?
(121)
•••
bingostar
X
Comment by
bingostar
on Feb 15, 2023 3:03pm
RE:RE:RE:What's going on?
Apparently im not the only that noticed the flaws of this company that just been hammered by negative recommendations of brokers.
Numinus Launches a Complete Psychedelic-Assisted Therapy Training Program
posted Mar 28, 2023 9:00am by
Numinus Wellness Inc.
-
|
The Certification Pathway develops core PAT skills through multi-modal teaching methods including interactive evidence and theory reviews, audio-visual design, case-based learning, experiential learning, in-person shadowing opportunities, and more. Once all course requirements in the Certification Pathway are completed, trained practitioners will receive a formal certificate from Numinus to designate competency in providing PAT using specific medicines. ...read more
(116)
•••
GoldenArm
X
Post by
GoldenArm
on Jan 13, 2023 11:44am
Looks like medac is being help up by FDA
Since the FDA get 75% of its funding from Pharma, I think Treos would get approved if medac just cut them a cheque. It is approved in Europe and in Canada, wtf does FDA need other than money since it
...more
(33)
•••
Rockafellow2
X
Comment by
Rockafellow2
on Nov 21, 2022 2:14pm
RE:RE:What's going on?
Bingo ... U have to admit that sales r important else no cash flow is possible so they r constantly selling approx 25 mil $ every quarter, so that seems to me a positive thing. When or if they get
...more
(121)
•••
bingostar
X
Comment by
bingostar
on Nov 19, 2022 9:41am
RE:What's going on?
Incorrect, you do not repay debt with sales only with cash flow and now they are cash flow breakeven. Their business model do not work , they pay to much for acquiring rights and also taking all the
...more
(33)
•••
Rockafellow2
X
Post by
Rockafellow2
on Nov 10, 2022 10:01am
What's going on?
Isn't 100mil debt good if that is needed to make 200mil in product? If they weren't selling anything that debt would sink them BUT making 25mil every quarter would wipe that debt out in one
...more
(121)
•••
bingostar
X
Comment by
bingostar
on Nov 09, 2022 2:28pm
RE:RE:RE:RE:Still moving up
They will have to raise cash soon with the load of debts they have , that is why they built that PR strategy to raise the SP avoiding massive dilution.
(121)
•••
bingostar
X
Comment by
bingostar
on Nov 09, 2022 10:01am
RE:RE:RE:Still moving up
The turnoff is their balance sheet with 90 M$ of debts with 30 M$ short term , cash is only 10 M$ and they posted a barely positive ebitda. No wonder they preannouced their sales figures cause nobody
...more
(896)
•••
prophetoffactz
X
Comment by
prophetoffactz
on Nov 09, 2022 8:14am
RE:RE:RE:Still moving up
The company pre-announced record revenue... You just had to plug the revenue number in and speculate with the rest going into the release yesterday. Medexus Announces Preliminary Revenue
...more
(26)
•••
bigreturn11
X
Comment by
bigreturn11
on Nov 09, 2022 12:35am
RE:RE:Still moving up
Absolutely terrible to see the share price move ahead of news. That thing is such a turnoff for shareholders or prospective investors. It's a page out of the mining world where those in the close
...more
(1591)
•••
lscfa
X
Comment by
lscfa
on Nov 08, 2022 6:43pm
RE:Still moving up
Mgmt needs to halt the stock before earnings releases or plug the damn leaks in the co.
(33)
•••
Rockafellow2
X
Post by
Rockafellow2
on Nov 08, 2022 3:44pm
Must b good news
Coming!
(121)
•••
bingostar
X
Post by
bingostar
on Nov 02, 2022 12:00pm
Q2
TORONTO and CHICAGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on
...more
(5)
•••
existabo
X
Comment by
existabo
on Oct 12, 2022 10:16am
RE:Still moving up
The best looking chart on the TSE, where are the broker covering this story... if anyone as info on what they are saying,thanks for sharing.
(33)
•••
Rockafellow2
X
Post by
Rockafellow2
on Oct 11, 2022 4:39pm
Still moving up
Slowly ... Big profits last quarter ... Something amiss ...???
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Herald Price Sensitive
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
This Silver Producer Outperformed Peers in Q4 and Looks Strong for 2023
ESG Dynamo Scores Big Again with Record Q4 and YE 2022 Results
Well-funded Mineral Exploration Company Focused on Exploring Economically Viable Mineral Deposits
Clean Energy VS. Renewable Energy, Which is Better and Why? Download Insights Report Here